Pharmacogenetic testing is the science of how genetics impacts an individual's response to medications. This advancement in genetic testing allows clinicians to target medications to improve patient outcomes.
PGT testing is a NON-INVASIVE tool to help patients and doctors provide the maximized benefits of drug therapy while minimizing the economic, physical and emotional burdens of ineffective trial and error type methods.
Lifestyle factors such as diet, age, alcohol and nicotine can all affect the medical interactions of prescribed medications and lead to inter-patient variability in medical response. Genetics remains one of the most compelling targets to evaluate in clinical practice because of the relative ease of measuring and quantifying its impact on patient response. PGT testing is a more consistent barometer for predicting medication response among patients.
There is a significant opportunity for PGT testing in both specialty and primary care settings. Genetic tests are performed typically once in a patients lifetime for a given gene and this information can be used repeatedly throughout the patients life to improve health without incurring additional expense.
A number of major medical institutions and centers have implemented PGT testing into routine care. Several of these major medical centers have coupled preemptive (pre-prescribing) PGT with popup alerts embedded within their EMR / EHR systems to help guide patient care. St. Jude's Hospital and the Mayo Clinic, Vanderbilt University, UNC-Chapel Hill and the University of Florida are just a few of these world renowned centers that have embraced PGT testing, shouldn't you?